BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17341731)

  • 21. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.
    Stickens D; Brown D; Evans GA
    Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The short-lived exostosis induced surgically versus the lasting genetic hereditary multiple exostoses.
    Trebicz-Geffen M; Nevo Z; Evron Z; Posternak N; Glaser T; Fridkin M; Kollander Y; Robinson D
    Exp Mol Pathol; 2003 Feb; 74(1):40-8. PubMed ID: 12645631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas.
    van Duin M; van Marion R; Vissers KJ; Hop WC; Dinjens WN; Tilanus HW; Siersema PD; van Dekken H
    Cytogenet Genome Res; 2007; 118(2-4):130-7. PubMed ID: 18000363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 20 novel point mutations and one large deletion in EXT1 and EXT2 genes: report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis.
    Ciavarella M; Coco M; Baorda F; Stanziale P; Chetta M; Bisceglia L; Palumbo P; Bengala M; Raiteri P; Silengo M; Caldarini C; Facchini R; Lala R; Cavaliere ML; De Brasi D; Pasini B; Zelante L; Guarnieri V; D'Agruma L
    Gene; 2013 Feb; 515(2):339-48. PubMed ID: 23262345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas.
    Weber RG; Hoischen A; Ehrler M; Zipper P; Kaulich K; Blaschke B; Becker AJ; Weber-Mangal S; Jauch A; Radlwimmer B; Schramm J; Wiestler OD; Lichter P; Reifenberger G
    Oncogene; 2007 Feb; 26(7):1088-97. PubMed ID: 16909113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic loss of an EXT2 gene mutation during malignant progression in a patient with hereditary multiple osteochondromas.
    Musso N; Caronia FP; Castorina S; Lo Monte AI; Barresi V; Condorelli DF
    Cancer Genet; 2015 Mar; 208(3):62-7. PubMed ID: 25744876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ext-mutation analysis in Italian sporadic and hereditary osteochondromas.
    Gigante M; Matera MG; Seripa D; Izzo AM; Venanzi R; Giannotti A; Digilio MC; Gravina C; Lazzari M; Monteleone G; Monteleone M; Dallapiccola B; Fazio VM
    Int J Cancer; 2001 Nov; 95(6):378-83. PubMed ID: 11668521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1).
    Ahn J; Lüdecke HJ; Lindow S; Horton WA; Lee B; Wagner MJ; Horsthemke B; Wells DE
    Nat Genet; 1995 Oct; 11(2):137-43. PubMed ID: 7550340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and functional characterization of the human EXT1 promoter region.
    Jennes I; Zuntini M; Mees K; Palagani A; Pedrini E; De Cock G; Fransen E; Vanden Berghe W; Sangiorgi L; Wuyts W
    Gene; 2012 Jan; 492(1):148-59. PubMed ID: 22037484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteochondroma formation is independent of heparanase expression as revealed in a mouse model of hereditary multiple exostoses.
    Mundy C; Chung J; Koyama E; Bunting S; Mahimkar R; Pacifici M
    J Orthop Res; 2022 Oct; 40(10):2391-2401. PubMed ID: 34996123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.
    Wuyts W; Radersma R; Storm K; Vits L
    Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes.
    Hecht JT; Hayes E; Haynes R; Cole WG; Long RJ; Farach-Carson MC; Carson DD
    Differentiation; 2005 Jun; 73(5):212-21. PubMed ID: 16026543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families.
    Jennes I; de Jong D; Mees K; Hogendoorn PC; Szuhai K; Wuyts W
    BMC Med Genet; 2011 Jun; 12():85. PubMed ID: 21703028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and functional analysis of mouse EXT1, a homolog of the human multiple exostoses type 1 gene.
    Lin X; Gan L; Klein WH; Wells D
    Biochem Biophys Res Commun; 1998 Jul; 248(3):738-43. PubMed ID: 9703997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas.
    Kyriazoglou AI; Dimitriadis E; Arnogiannaki N; Brandal P; Heim S; Pandis N
    Cancer Genet; 2011 Dec; 204(12):677-81. PubMed ID: 22285020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis.
    Hall CR; Cole WG; Haynes R; Hecht JT
    Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.
    McCormick C; Leduc Y; Martindale D; Mattison K; Esford LE; Dyer AP; Tufaro F
    Nat Genet; 1998 Jun; 19(2):158-61. PubMed ID: 9620772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
    Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
    Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intronic deletion and duplication proximal of the EXT1 gene: a novel causative mechanism for multiple osteochondromas.
    Waaijer CJ; Winter MG; Reijnders CM; de Jong D; John Ham S; Bovée JV; Szuhai K
    Genes Chromosomes Cancer; 2013 Apr; 52(4):431-6. PubMed ID: 23341036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.